SCHEMBL3667550

SCHEMBL3667550

NCCSc1ccc(SCCN)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
MAPK1 P28482 1/20 0.48
CA2 P00918 6/20 0.40
CA12 O43570 3/20 0.40
CA1 P00915 3/20 0.40
CA7 P43166 3/20 0.40
CA13 Q8N1Q1 3/20 0.40
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
CYP1A2 P05177 3/20 0.37
CYP2D6 P10635 3/20 0.37
CYP2C19 P33261 3/20 0.37
TSHR P16473 2/20 0.37
THPO P40225 1/20 0.37
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
DDAH1 O94760 1/20 0.36
ADRA2C P18825 1/20 0.36
STAT6 P42226 1/20 0.36
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23916317 0.89 MAPK1 (0.48) ALDH1A1MAPK1CA2CA12CA1
SCHEMBL6192990 0.87 MAPT (0.45) ALDH1A1MAOAMAOBTSHRKIF11
SCHEMBL8348563 0.87 SLC6A4 (0.43) ALDH1A1MAPK1CA2CA12CA1
SCHEMBL5382245 0.87 CA2 (0.50) ALDH1A1MAPK1CA2CA12CA1
SCHEMBL1569974 0.87 NPC1 (0.52) ALDH1A1MAPK1CYP1A2CYP2C19CYP3A4
SCHEMBL4373571 0.87 SMN1; SMN2 (0.50) ALDH1A1MAPK1MAOAMAOBKIF11
SCHEMBL2154362 0.87 SLC6A4 (0.50) ALDH1A1CYP1A2CYP2D6CYP2C19TSHR
SCHEMBL376816 0.86 ALDH1A1 (0.70) ALDH1A1MAPK1MAOAMAOBCYP1A2
Hydrochloric Acid SCHEMBL5384426 0.85 CA2 (0.48) ALDH1A1MAPK1CA2CA12CA1
Hydrochloric Acid SCHEMBL6243015 0.85 SLC6A4 (0.42) ALDH1A1MAPK1CA2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8384982-B2 Display element KONICA MINOLTA HOLDINGS, INC. (JP) 2013-02-26 US disclosed
US-8384982-B2 Display element KONICA MINOLTA HOLDINGS, INC. (JP) 2013-02-26 US disclosed
US-8264423-B2 Method of driving display element KONICA MINOLTA HOLDINGS, INC. (JP) 2012-09-11 US disclosed
US-8254012-B2 Display element KONICA MINOLTA HOLDINGS, INC. (JP) 2012-08-28 US disclosed
US-8094360-B2 Room temperature molten salt and display element KONICA MINOLTA HOLDINGS, INC. (JP) 2012-01-10 US disclosed
US-8049948-B2 Process for producing electrochemical display element and electrochemical display element KONICA MINOLTA HOLDINGS, INC. (JP) 2011-11-01 US disclosed
US-7880950-B2 low drive voltage, high display contrast, high reflectance and small variation of the reflectance of white display; exhibiting a decreased color change in white display after repeated driving operation of the display element KONICA MINOLTA HOLDINGS, INC. (JP) 2011-02-01 US disclosed
US-7864407-B2 Display element KONICA MINOLTA HOLDINGS, INC. (JP) 2011-01-04 US disclosed
US-20100315391-A1 METHOD OF DRIVING DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2010-12-16 US disclosed
US-20100213813-A1 DISPLAY ELEMENT EDISON INNOVATIONS LLC 2010-08-26 US disclosed
US-20090180170-A1 DISPLAY ELEMENT AND PRODUCTION METHOD THEREOF KONICA MINOLTA HOLDINGS, INC. (JP) 2009-07-16 US disclosed
US-20090103169-A1 DISPLAY ELEMENT Konica Minolta, Inc. (JP) 2009-04-23 US disclosed
US-7518777-B2 Display element KONICA MINOLTA HOLDINGS, INC. (JP) 2009-04-14 US disclosed
US-20090091234-A1 ROOM TEMPERATURE MOLTEN SALT AND DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2009-04-09 US disclosed
WO-2008113364-A2 AMINO DERIVATIVES TO PREVENT NEPHROTOXICITY AND CANCER RECEPTICON APS (DK) 2008-09-25 WO disclosed
US-20080204849-A1 Display Element KONICA MINOLTA HOLDINGS, INC. (JP) 2008-08-28 US disclosed
US-20080170288-A1 Display Element and Driving Method Thereof KONICA MINOLTA HOLDINGS, INC. (JP) 2008-07-17 US disclosed
US-20080166590-A1 Display Element KONICA MINOLTA HOLDINGS, INC. (JP) 2008-07-10 US disclosed
EP-1845409-A1 DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2007-10-17 EP disclosed
EP-1845410-A1 DISPLAY ELEMENT AND METHOD FOR DRIVING SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2007-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090091234-A1 ROOM TEMPERATURE MOLTEN SALT AND DISPLAY ELEMENT SAV1, TYR, MPST ALDH1A1 710/4885MAPK1 1446/4885CA2 313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.